Calendar

Oct
15
Fri
Severe Asthma: Reducing Disease Burden with Step-Up Therapy
Oct 15 2021 @ 7:10 am – Oct 15 2022 @ 8:10 am


Severe Asthma: Reducing Disease Burden with Step-Up Therapy

View Activity

FACULTY

Geoffrey Chupp, MD
Professor of Medicine (Pulmonary)
Director, Yale Center for Asthma and Airways Disease (YCAAD)
New Haven, CT

Wanda Phipatanakul, MD, MS
Division of Asthma/Allergy and Immunology
Director of the Asthma/Allergy and Immunology Research Center
Professor of Pediatrics, Harvard Medical School
Boston, MA

Maureen George, PhD, RN, AE-C, FAAN
Professor of Nursing at CUIMC
Columbia University School of Nursing
New York, NY

PROGRAM OVERVIEW

This case-based live-virtual activity will cover the treatment and management of patients with severe asthma.

TARGET AUDIENCE

This CME activity is designed to meet the educational needs of pulmonologists, allergists, primary care physicians, pediatricians, and other healthcare providers involved in the management of patients with severe uncontrolled asthma.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Assess disease severity and intensify therapy as needed to manage the symptoms and quality-of-life issues associated with uncontrolled severe asthma in pediatric and adult patients
  • Utilize biomarkers and asthma phenotypes to personalize the selection of treatment options for pediatric and adult patients with severe asthma
  • Incorporate current treatment recommendations and clinical trial data for the management of severe asthma into clinical practice

ACCREDITATION STATEMENT

This program would be beneficial for nurses involved in the care of patients with severe asthma.
CNE credits: 1.0 ANCC Contact Hour.

CREDIT DESIGNATION STATEMENT

Med Learning Group will designate each virtual live meeting and simulcast for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the live-virtual activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with severe asthma.
CNE credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Geoffrey Chupp, MD Dr. Chupp is a member of Speakers Bureau for GSK, AstraZeneca, Genentech, Regeneron, Sanofi, Teva, and Amgen.

Wanda Phipatanakul, MD Dr. Phipatanakul discloses that she has worked as a Consultant for Genentech, Novartis, Regeneron, Sanofi, Teva and GSK.

Maureen George, PhD, RN, AE-C, FAAN Dr. George is a consultant for AstraZeneca, Genentech, Sanofi Regeneron, and Teva. She also is a Speaker’s Bureau member for AstraZeneca, Genentech, and Teva.

Bridgette L. Jones, MD MS FAAAAI FAAP Dr. Jones receives fees for Non-CME/CE Services from Merck Manuals as a paid chapter author.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose

CME Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Michael Page, PharmD, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit, participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the online activity
  3. Complete posttest and evaluation form online.

Participants will receive their certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

RELEASE DATE: October 15, 2021

EXPIRATION DATE: October 15, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

View Activity